| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |